ASX - By Stock
|
IRX |
Re:
Ann: BodyTel Platform to be Extended to Fever Tracking
|
|
sidage
|
39 |
13K |
5 |
25/03/20 |
25/03/20 |
ASX - By Stock
|
39
|
13K
|
5
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann Receives R&D Tax Incentive Refund of $1.2m
|
|
sidage
|
42 |
14K |
6 |
23/03/20 |
23/03/20 |
ASX - By Stock
|
42
|
14K
|
6
|
|
ASX - By Stock
|
TSN |
Re:
Ann: Final Director's Interest Notice
|
|
sidage
|
5 |
2.3K |
0 |
23/03/20 |
23/03/20 |
ASX - By Stock
|
5
|
2.3K
|
0
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann Receives R&D Tax Incentive Refund of $1.2m
|
|
sidage
|
42 |
14K |
1 |
23/03/20 |
23/03/20 |
ASX - By Stock
|
42
|
14K
|
1
|
|
ASX - By Stock
|
AGH |
Re:
Ann: Extension of Voluntary Escrow
|
|
sidage
|
1 |
1.5K |
3 |
23/03/20 |
23/03/20 |
ASX - By Stock
|
1
|
1.5K
|
3
|
|
ASX - By Stock
|
EXL |
Re:
SP Discussion
|
|
sidage
|
1.7K |
1.0M |
2 |
21/03/20 |
21/03/20 |
ASX - By Stock
|
1.7K
|
1.0M
|
2
|
|
ASX - By Stock
|
AC8 |
Re:
Hard Shell
|
|
sidage
|
21 |
6.6K |
2 |
20/03/20 |
20/03/20 |
ASX - By Stock
|
21
|
6.6K
|
2
|
|
ASX - By Stock
|
TSN |
Re:
Ann: Change of Chief Executive Officer and Board
|
|
sidage
|
1 |
1.1K |
6 |
13/03/20 |
13/03/20 |
ASX - By Stock
|
1
|
1.1K
|
6
|
|
ASX - By Stock
|
AGH |
Re:
Trying to scale a loss making business exacerbates the loss
|
|
sidage
|
58 |
750K |
4 |
12/03/20 |
12/03/20 |
ASX - By Stock
|
58
|
750K
|
4
|
|
ASX - By Stock
|
TSN |
Re:
Short Runway
|
|
sidage
|
30 |
340K |
1 |
10/03/20 |
10/03/20 |
ASX - By Stock
|
30
|
340K
|
1
|
|
ASX - By Stock
|
AGH |
Re:
Trying to scale a loss making business exacerbates the loss
|
|
sidage
|
58 |
750K |
1 |
05/03/20 |
05/03/20 |
ASX - By Stock
|
58
|
750K
|
1
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Investor Presentation
|
|
sidage
|
3 |
2.0K |
5 |
05/03/20 |
05/03/20 |
ASX - By Stock
|
3
|
2.0K
|
5
|
|
ASX - By Stock
|
AGH |
Re:
Trying to scale a loss making business exacerbates the loss
|
|
sidage
|
58 |
750K |
2 |
05/03/20 |
05/03/20 |
ASX - By Stock
|
58
|
750K
|
2
|
|
ASX - By Stock
|
AGH |
Re:
Trying to scale a loss making business exacerbates the loss
|
|
sidage
|
58 |
750K |
3 |
05/03/20 |
05/03/20 |
ASX - By Stock
|
58
|
750K
|
3
|
|
ASX - By Stock
|
AGH |
Re:
UK Market News
|
|
sidage
|
5 |
4.2K |
2 |
04/03/20 |
04/03/20 |
ASX - By Stock
|
5
|
4.2K
|
2
|
|
ASX - By Stock
|
AGH |
Re:
Trying to scale a loss making business exacerbates the loss
|
|
sidage
|
58 |
750K |
1 |
02/03/20 |
02/03/20 |
ASX - By Stock
|
58
|
750K
|
1
|
|
ASX - By Stock
|
AGH |
Re:
Trying to scale a loss making business exacerbates the loss
|
|
sidage
|
58 |
750K |
3 |
02/03/20 |
02/03/20 |
ASX - By Stock
|
58
|
750K
|
3
|
|
ASX - By Stock
|
IRX |
Re:
Ann: Section 708A Notice
|
|
sidage
|
7 |
133K |
0 |
02/03/20 |
02/03/20 |
ASX - By Stock
|
7
|
133K
|
0
|
|
ASX - By Stock
|
TSN |
Re:
Short Runway
|
|
sidage
|
30 |
340K |
1 |
01/03/20 |
01/03/20 |
ASX - By Stock
|
30
|
340K
|
1
|
|
ASX - By Stock
|
TSN |
Re:
Short Runway
|
|
sidage
|
30 |
340K |
1 |
01/03/20 |
01/03/20 |
ASX - By Stock
|
30
|
340K
|
1
|
|
ASX - By Stock
|
TSN |
Re:
Short Runway
|
|
sidage
|
30 |
340K |
0 |
01/03/20 |
01/03/20 |
ASX - By Stock
|
30
|
340K
|
0
|
|
ASX - By Stock
|
TSN |
Re:
Short Runway
|
|
sidage
|
30 |
340K |
0 |
29/02/20 |
29/02/20 |
ASX - By Stock
|
30
|
340K
|
0
|
|
ASX - By Stock
|
AGH |
Re:
Trying to scale a loss making business exacerbates the loss
|
|
sidage
|
58 |
750K |
3 |
29/02/20 |
29/02/20 |
ASX - By Stock
|
58
|
750K
|
3
|
|
ASX - By Stock
|
AGH |
Re:
Trying to scale a loss making business exacerbates the loss
|
|
sidage
|
58 |
750K |
2 |
28/02/20 |
28/02/20 |
ASX - By Stock
|
58
|
750K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
News: ZLD Zelda Therapeutics Posts HY Comprehensive Loss For Period Of $2.6 Mln
|
|
sidage
|
106 |
2.1M |
2 |
28/02/20 |
28/02/20 |
ASX - By Stock
|
106
|
2.1M
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
News: ZLD Zelda Therapeutics Posts HY Comprehensive Loss For Period Of $2.6 Mln
|
|
sidage
|
106 |
2.1M |
2 |
28/02/20 |
28/02/20 |
ASX - By Stock
|
106
|
2.1M
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
News: ZLD Zelda Therapeutics Posts HY Comprehensive Loss For Period Of $2.6 Mln
|
|
sidage
|
106 |
2.1M |
3 |
28/02/20 |
28/02/20 |
ASX - By Stock
|
106
|
2.1M
|
3
|
|
ASX - By Stock
|
TSN |
Re:
Short Runway
|
|
sidage
|
30 |
340K |
1 |
28/02/20 |
28/02/20 |
ASX - By Stock
|
30
|
340K
|
1
|
|
ASX - By Stock
|
EMD |
Re:
IPO - Emerald Clinics Limited
|
|
sidage
|
57 |
171K |
1 |
28/02/20 |
28/02/20 |
ASX - By Stock
|
57
|
171K
|
1
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Pause in Trading
|
|
sidage
|
7 |
51K |
2 |
28/02/20 |
28/02/20 |
ASX - By Stock
|
7
|
51K
|
2
|
|
ASX - By Stock
|
AGH |
Re:
Trying to scale a loss making business exacerbates the loss
|
|
sidage
|
58 |
750K |
6 |
28/02/20 |
28/02/20 |
ASX - By Stock
|
58
|
750K
|
6
|
|
ASX - By Stock
|
AGH |
Trying to scale a loss making business exacerbates the loss
|
|
sidage
|
58 |
750K |
5 |
28/02/20 |
28/02/20 |
ASX - By Stock
|
58
|
750K
|
5
|
|
ASX - By Stock
|
TSN |
Re:
Short Runway
|
|
sidage
|
30 |
340K |
0 |
27/02/20 |
27/02/20 |
ASX - By Stock
|
30
|
340K
|
0
|
|
ASX - By Stock
|
BOD |
Re:
Ticks off 373 MediCabilis prescriptions
|
|
sidage
|
9 |
28K |
0 |
27/02/20 |
27/02/20 |
ASX - By Stock
|
9
|
28K
|
0
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Emerald to Conduct Opioid Sparing Clinical Trial for Zelira
|
|
sidage
|
1 |
10K |
6 |
27/02/20 |
27/02/20 |
ASX - By Stock
|
1
|
10K
|
6
|
|
ASX - By Stock
|
AGH |
Re:
Ann: Half Yearly Report and Accounts
|
|
sidage
|
21 |
51K |
4 |
26/02/20 |
26/02/20 |
ASX - By Stock
|
21
|
51K
|
4
|
|
ASX - By Stock
|
TSN |
Re:
Short Runway
|
|
sidage
|
30 |
340K |
4 |
26/02/20 |
26/02/20 |
ASX - By Stock
|
30
|
340K
|
4
|
|
ASX - By Stock
|
AGH |
Re:
Ann: Half Yearly Report and Accounts
|
|
sidage
|
21 |
51K |
4 |
26/02/20 |
26/02/20 |
ASX - By Stock
|
21
|
51K
|
4
|
|
ASX - By Stock
|
IRX |
Re:
Juul Reach 15 Billion Market Cap Within 2 Years
|
|
sidage
|
44 |
58K |
0 |
26/02/20 |
26/02/20 |
ASX - By Stock
|
44
|
58K
|
0
|
|
ASX - By Stock
|
IRX |
Re:
Juul Reach 15 Billion Market Cap Within 2 Years
|
|
sidage
|
44 |
58K |
0 |
26/02/20 |
26/02/20 |
ASX - By Stock
|
44
|
58K
|
0
|
|
ASX - By Stock
|
LGP |
Re:
IPO - Little Green Pharma Ltd
|
|
sidage
|
112 |
306K |
3 |
24/02/20 |
24/02/20 |
ASX - By Stock
|
112
|
306K
|
3
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: CH2 appointed to distribute AusCann's products in Australia
|
|
sidage
|
41 |
66K |
6 |
24/02/20 |
24/02/20 |
ASX - By Stock
|
41
|
66K
|
6
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: CH2 appointed to distribute AusCann's products in Australia
|
|
sidage
|
41 |
66K |
8 |
24/02/20 |
24/02/20 |
ASX - By Stock
|
41
|
66K
|
8
|
|
ASX - By Stock
|
IRX |
Re:
dead as a door nail waiting for resuscitation?
|
|
sidage
|
3 |
5.2K |
0 |
23/02/20 |
23/02/20 |
ASX - By Stock
|
3
|
5.2K
|
0
|
|
ASX - By Stock
|
IRX |
dead as a door nail waiting for resuscitation?
|
|
sidage
|
3 |
5.2K |
0 |
23/02/20 |
23/02/20 |
ASX - By Stock
|
3
|
5.2K
|
0
|
|
ASX - By Stock
|
BOD |
Re:
Ticks off 373 MediCabilis prescriptions
|
|
sidage
|
9 |
28K |
1 |
23/02/20 |
23/02/20 |
ASX - By Stock
|
9
|
28K
|
1
|
|
ASX - By Stock
|
VIT |
Re:
How we value CAU
|
|
sidage
|
19 |
64K |
0 |
22/02/20 |
22/02/20 |
ASX - By Stock
|
19
|
64K
|
0
|
|
ASX - By Stock
|
LGP |
Re:
IPO - Little Green Pharma Ltd
|
|
sidage
|
112 |
306K |
2 |
21/02/20 |
21/02/20 |
ASX - By Stock
|
112
|
306K
|
2
|
|
ASX - By Stock
|
LGP |
Re:
IPO - Little Green Pharma Ltd
|
|
sidage
|
112 |
306K |
4 |
21/02/20 |
21/02/20 |
ASX - By Stock
|
112
|
306K
|
4
|
|
ASX - By Stock
|
VIT |
Re:
How we value CAU
|
|
sidage
|
19 |
64K |
0 |
21/02/20 |
21/02/20 |
ASX - By Stock
|
19
|
64K
|
0
|
|